Jinling Pharmaceutical Co Ltd (000919) — Free Cash Flow Generation Index
Jinling Pharmaceutical Co Ltd (000919) has a Free Cash Flow Generation Index of 0.83x as of September 2025. Free cash flow of CN¥61.45 Million represents 1% of operating cash flow (CN¥74.01 Million). Explore 000919 capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Jinling Pharmaceutical Co Ltd Free Cash Flow Generation Index (1999–2024)
Historical FCF Generation Index trend for Jinling Pharmaceutical Co Ltd across 26 annual periods. For the full cash flow conversion analysis, see 000919 cash flow metrics.
Annual Free Cash Flow Generation for Jinling Pharmaceutical Co Ltd (1999–2024)
Year-by-year Free Cash Flow Generation Index for Jinling Pharmaceutical Co Ltd. Check 000919 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.31x | CN¥-47.44 Million | CN¥154.19 Million | CN¥201.63 Million | ▼ -89.1% |
| 2023 | -0.16x | CN¥-25.85 Million | CN¥158.92 Million | CN¥186.25 Million | ▲ +13.6% |
| 2022 | -0.19x | CN¥-49.05 Million | CN¥260.59 Million | CN¥309.64 Million | ▼ -142.5% |
| 2021 | 0.44x | CN¥129.26 Million | CN¥292.03 Million | CN¥162.76 Million | ▲ +587.4% |
| 2020 | 0.06x | CN¥20.06 Million | CN¥311.46 Million | CN¥291.41 Million | ▼ -91.2% |
| 2019 | 0.73x | CN¥340.13 Million | CN¥465.85 Million | CN¥125.71 Million | ▲ +6.5% |
| 2018 | 0.69x | CN¥297.41 Million | CN¥433.83 Million | CN¥136.42 Million | ▼ -19.3% |
| 2017 | 0.85x | CN¥376.31 Million | CN¥443.11 Million | CN¥66.80 Million | ▲ +822.4% |
| 2016 | -0.12x | CN¥-11.30 Million | CN¥96.15 Million | CN¥107.45 Million | ▼ -123.1% |
| 2015 | 0.51x | CN¥108.14 Million | CN¥212.45 Million | CN¥104.31 Million | ▼ -26.9% |
| 2014 | 0.70x | CN¥208.75 Million | CN¥299.89 Million | CN¥91.14 Million | ▲ +48.5% |
| 2013 | 0.47x | CN¥127.16 Million | CN¥271.21 Million | CN¥144.05 Million | ▲ +151.0% |
| 2012 | 0.19x | CN¥43.36 Million | CN¥232.12 Million | CN¥188.76 Million | ▼ -64.4% |
| 2011 | 0.52x | CN¥90.62 Million | CN¥172.82 Million | CN¥82.20 Million | ▲ +13.2% |
| 2010 | 0.46x | CN¥82.33 Million | CN¥177.81 Million | CN¥95.48 Million | ▼ -5.0% |
| 2009 | 0.49x | CN¥91.81 Million | CN¥188.41 Million | CN¥96.60 Million | ▼ -47.5% |
| 2008 | 0.93x | CN¥283.15 Million | CN¥305.26 Million | CN¥22.11 Million | ▲ +12.8% |
| 2007 | 0.82x | CN¥97.09 Million | CN¥118.06 Million | CN¥20.97 Million | ▼ -1.3% |
| 2006 | 0.83x | CN¥115.41 Million | CN¥138.50 Million | CN¥23.09 Million | ▲ +25.3% |
| 2005 | 0.67x | CN¥72.69 Million | CN¥109.29 Million | CN¥36.61 Million | ▲ +21.7% |
| 2004 | 0.55x | CN¥87.34 Million | CN¥159.81 Million | CN¥72.47 Million | ▼ -15.9% |
| 2003 | 0.65x | CN¥105.13 Million | CN¥161.86 Million | CN¥56.73 Million | ▲ +205.3% |
| 2002 | 0.21x | CN¥27.73 Million | CN¥130.36 Million | CN¥102.63 Million | ▲ +129.0% |
| 2001 | -0.73x | CN¥-67.78 Million | CN¥92.49 Million | CN¥160.27 Million | ▼ -275.1% |
| 2000 | 0.42x | CN¥96.81 Million | CN¥231.31 Million | CN¥134.49 Million | ▲ +152.3% |
| 1999 | -0.80x | CN¥-31.80 Million | CN¥39.77 Million | CN¥71.57 Million | — |